Contenuto principale della pagina Menu di navigazione Modulo di ricerca su uniPi Modulo di ricerca su uniPi

IMI 2

 

IMI logo

 

The Innovative Medicines Initiative (IMI) is a large-scale public–private partnership between the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The goal of IMI, particularly in its second phase (IMI2, 2014-2020) is to develop next generation vaccines, medicines and treatments, such as new antibiotics.


Within IMI2 the University of Pisa is partner to 4 projects:

Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes

Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification

Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions

Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA

Questo sito utilizza solo cookie tecnici, propri e di terze parti, per il corretto funzionamento delle pagine web e per il miglioramento dei servizi. Se vuoi saperne di più, consulta l'informativa